Neither peptide is approved by the FDA or comparable regulators as a hair-loss treatment, and neither has completed a human efficacy trial for that purpose
Phase 2 data showed weight loss around 24% at 48 weeks, but retatrutide is still earlier in development
Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules
When they don't, follicles remain dormant
Some users on review platforms reported minimal appetite suppression from the tablet form, which could relate to absorption variability
Any new or worsening symptom, particularly severe abdominal pain, persistent vomiting, yellowing of the skin or eyes, or signs of allergic reaction, requires prompt medical attention